Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T17:28:16.454Z Has data issue: false hasContentIssue false
  • English
  • Français

The G2019S LRRK2 Mutation is Rare in Korean Patients with Parkinson's Disease

Published online by Cambridge University Press:  02 December 2014

Jin-Whan Cho ,
Sung-Yeon Kim ,
Sung-Sup Park ,
Han-Jun Kim ,
Tae-Beom Ahn ,
Jong-Min Kim  and
Beom-Seok Jeon
Jin-Whan Cho
Affiliation:
Department of Neurology, BK-21 and MRC, College of Medicine, Seoul National University and the Boramae City Hospital, Seoul, South Korea
Sung-Yeon Kim
Affiliation:
Department of Laboratory Medicine, BK-21 and MRC, College of Medicine, Seoul National University and the Seoul National University Hospital, Seoul, South Korea
Sung-Sup Park
Affiliation:
Department of Laboratory Medicine, BK-21 and MRC, College of Medicine, Seoul National University and the Seoul National University Hospital, Seoul, South Korea
Han-Jun Kim
Affiliation:
Department of Neurology, BK-21 and MRC, College of Medicine, Seoul National University and the Seoul National University Hospital Seoul, South Korea
Tae-Beom Ahn
Affiliation:
Departments of Neurology, BK-21 and MRC, College of Medicine, Seoul National, University and the Kyeong-Hee University, Seoul, South Korea
Jong-Min Kim
Affiliation:
Department of Neurology, BK-21 and MRC, College of Medicine, Seoul National University and the Bundang Hospital, Seoul, South Korea
Beom-Seok Jeon
Affiliation:
Department of Neurology, BK-21 and MRC, College of Medicine, Seoul National University and the Seoul National University Hospital, Seoul, South Korea
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

A number of causative mutations such as a-synuclein, parkin, UCHL1, Pink-1, DJ-1 have been identified in Parkinson's disease (PD). They are usually found in the familial cases. One mutation of great interest is the G2019S mutation in the LRRK2 gene, which has been reported in both familial and sporadic PD. Its prevalence has been reported to vary markedly among different races. We examined the prevalence of the G2019S mutation in the Korean PD population for genetic study planning.

Methods:

We conducted a genetic analysis of the G2019S mutation by standard PCR and restriction digestion method. 453 PD patients were studied, 34% of whom had an age at onset of <50 years and 3.8% had a positive family history.

Results:

None of the 453 study subjects carried the G2019S mutation.

Conclusion:

Our result confirms previous reports that the G2019S mutation is rare among PD patients in the Asian population. This result supports the notion that the prevalence of this LRRK2 mutation is population specific, and that there may be a founder effect within western populations.

Résumé:

RÉSUMÉ: Contexte:

Quelques mutations causales ont été identifiées dans la maladie de Parkinson (MP) telles des mutations des gènes de l'a-synucléine, de la parkine, de l'UCHL1, de la Pink-1 et de la DJ-1. Il s'agit habituellement de cas familiaux. La mutation G2019S du gène LRRK2, qui a été rapportée chez des cas familiaux de MP et chez des cas sporadiques, est très intéressante. Sa prévalence varie beaucoup selon la race. Nous avons examiné la prévalence de la mutation G2019S dans la population coréenne de patients atteints de la maladie de Parkinson afin de planifier une étude génétique.

Méthodes:

Nous avons réalisé une analyse génétique de la mutation G2019S par la méthode standard d'amplification en chaîne par polymérase et digestion par enzyme de restriction. 453 patients atteints de MP ont été étudiés. L'âge de début était < 50 ans chez 34% des patients et 3,8% avaient une histoire familiale de MP.

Résultats:

Aucun des 453 patients n'était porteur de la mutation G2019S.

Conclusions:

Nos résultats confirment des publications antérieures selon lesquelles la mutation G2019S est rare chez les patients atteints de la MP dans la population asiatique. Ce résultat appui la notion que la prévalence de cette mutation du gène LRRK2 est spécifique de la population et qu'il pourrait exister un effet fondateur dans les populations occidentales.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 34 , Issue 1 , February 2007 , pp. 53 - 55
Copyright
Copyright © The Canadian Journal of Neurological 2007

References

1. Hofer, A, Gasser, T. New aspects of genetic contributions to Parkinson’s disease. J Mol Neurosci. 2004;24:417–24.Google Scholar
2. Paisan-Ruiz, C, Jain, S, Evans, EW, van der Brug, M, de Munain, AL, Aparicio, S, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron. 2004;44: 595–600.CrossRefGoogle ScholarPubMed
3. Zimprich, A, Biskup, S, Leitner, P, Lichtner, P, Farrer, M, Lincoln, S, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004; 44:601–7.Google Scholar
4. Funayama, M, Hasegawa, K, Ohta, E, Kawashima, N, Komiyama, M, Kowa, H, et al. An LRRK2 mutation as a cause for the Parkinsonism in the original PARK8 family. Ann Neurol. 2005;57:918–21.CrossRefGoogle ScholarPubMed
5. Aasly, JO, Toft, M, Fernandez-Mata, I, Kachergus, J, Hulihan, M, White, LR, et al. Clinical features of LRRK2-associated Parkinson’s disease in central Norway. Ann Neurol. 2005; 57:762–65.Google Scholar
6. Bras, JM, Guerreiro, RJ, Ribeiro, MH, Januario, C, Morgadinho, A, Oliveira, CR, et al. G2019S Dardarin substitution is a common cause of Parkinson’s disease in a Portuguese cohort. Mov Dis. 2005;20:1653–55.CrossRefGoogle Scholar
7. Fonzo, AD, Rohe, CF, Ferreira, J, Chien, HF, Vacca, L, Stocchi, F, et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson’s disease. Lancet. 2005;365:412–15.Google Scholar
8. Gilks, WP, Abou-Sleiman, PM, Gandhi, S, Jain, S, Singleton, A, Lees, A, et al. A common LRRK2 mutation in idiopathic Parkinson’s disease. Lancet. 2005;365:415–16.Google Scholar
9. Zabetian, CP, Samii, A, Mosley, AD, Roberts, JW, Leis, BC, Yearout, D, et al. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology. 2005;65:741–4.Google Scholar
10. Goldwurm, S, Fonzo, AD, Simons, EJ, Rohe, CF, Zini, M, Canesi, M, et al. The G6055A(G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor. J Med Genet. 2005;42:e65.CrossRefGoogle ScholarPubMed
11. Kay, DM, Zabetian, CP, Factor, SA, Nutt, JG, Samii, A, Griffith, A, et al. Parkinson’s disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Mov Dis. 2006; 21:519–23.Google Scholar
12. Mata, IF, Taylor, JP, Kachergus, J, Hulihan, M, Huerta, C, Lahoz, C, et al. LRRK2 R1141G in Spanish patients with Parkinson’s disease. Neurosci lett. 2005;382:309–11.CrossRefGoogle ScholarPubMed
13. Lesage, S, Durr, A, Tazir, M, Lohmann, E, Leutenegger, AL, Janin, S, et al. LRRK2 G2019S as a cause of Parkinson’s disease in North African Arabs. N Engl J Med. 2006 Jan 26;354:422–3.Google Scholar
14. Ozelius, LJ, Senthil, G, Saunder-Pullman, R, Ohmann, E, Deligtisch, A, Tagliati, M, et al. LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews. N Engl J Med. 2006; 354:424–5.CrossRefGoogle ScholarPubMed
15. Infante, J, Rodriguez, E, Combarros, O, Mateo, I, Fontalba, A, Pascual, J, et al. RRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson’s disease. Neurosci Lett 2006; 395:224–6.CrossRefGoogle Scholar
16. Lu, CS, Simons, EJ, Wu-Chou, YH, Fonzo, AD, Chang, HC, Chen, RS, et al. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson’s disease. Parkinsonism Relat Disord. 2005;11:521–2.Google Scholar
17. Tan, EK, Shen, H, Tan, LCS, Farrer, M, Yew, K, Chua, E, et al. The G2019S LRRK2 mutation in uncommon in an Asian cohort of Parkinson’s disease patients. Neurosci lett. 2005;384:327–9.CrossRefGoogle Scholar
18. Brice, A. Genetics of Parkinson’s disease. LRRK2 on the rise. Brain. 2005;128:2760–2.CrossRefGoogle ScholarPubMed
19. Kachergus, J, Mata, IF, Hulihan, M, Taylor, JP, Lincoln, S, Aasly, J, et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet. 2005;76: 672–80.Google Scholar
20. Bialecka, M, Hui, S, Duda, GK, Opala, G, Tan, EK, Drozdzik, M. Analysis of LRRK2 G2019S and I2020T mutations in Parkinson’s disease. Neurosci letter. 2005;390:1–3.Google Scholar